Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALONGA LAB
Original Assignee
ALONGA LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALONGA LABfiledCriticalALONGA LAB
Priority to ES8901815ApriorityCriticalpatent/ES2011587A6/en
Publication of ES2011587A6publicationCriticalpatent/ES2011587A6/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
According to this procedure for obtaining a derivative of pyrrolidone and salts thereof, N-[2-(diisopropylamino)ethyl]-oxo-1-pyrrolidinacetamide is obtained by condensation between N-[2-(diisopropylamino)ethyl]-2-chloroacetamide and a salt of 2-pyrrolidone, and subsequent salification thereof. The product has nootropic applications.
ES8901815A1989-05-291989-05-29Procedure for obtaining a derivative of pyrrolidone and salts thereof
Expired - Fee RelatedES2011587A6
(en)
3-(n-methyl-n-alkyl)-amino 2-methoxymethylene propan 1-ol derivatives, a preparation process of the same and therapeutical compositions containing them
Process for the preparation of 1-cycloprolyl-6-fluoro-1,4- dihydro-7-{(1S,4S)-5-methyl-2,5-diazabicyclo{2,2,1)-hept-2-yl}-4-oxo-3-quinolinocarboxylic acid and the salts.